Matches in Nanopublications for { <http://rdf.disgenet.org/resource/nanopub/NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_assertion type Assertion NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_head.
- NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_assertion description "[Although polymorphisms in renin-angiotensin-aldosterone (RAA) system genes for angiotensinogen (AGT M235T), angiotensin-converting enzyme (ACE I/D), angiotensin II type 1 receptor (AT1 A/C1166), and aldosterone synthase (CYP11B2-344T/C) have been major targets for genetic investigation in association with essential hypertension (EH), the influence of these genetic factors is still to be determined.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_provenance.
- NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_assertion evidence source_evidence_literature NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_provenance.
- NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_assertion SIO_000772 17190732 NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_provenance.
- NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_assertion wasDerivedFrom befree-2016 NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_provenance.
- NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_assertion wasGeneratedBy ECO_0000203 NP586142.RAZkxV3t1uFHxypN8Gm4Rcn2slvPcvfqLcdZWGe4B3JQU130_provenance.